These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 36381584)
1. Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis. Ma YS; Chu KJ; Ling CC; Wu TM; Zhu XC; Liu JB; Yu F; Li ZZ; Wang JH; Gao QX; Yi B; Wang HM; Gu LP; Li L; Tian LL; Shi Y; Jiang XQ; Fu D; Zhang XW Mol Ther Nucleic Acids; 2022 Dec; 30():324. PubMed ID: 36381584 [TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis. Ma YS; Chu KJ; Ling CC; Wu TM; Zhu XC; Liu JB; Yu F; Li ZZ; Wang JH; Gao QX; Yi B; Wang HM; Gu LP; Li L; Tian LL; Shi Y; Jiang XQ; Fu D; Zhang XW Mol Ther Nucleic Acids; 2020 Sep; 21():229-241. PubMed ID: 32585630 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis. Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989 [TBL] [Abstract][Full Text] [Related]
4. LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4. Wang J; Tang Q; Lu L; Luo Z; Li W; Lu Y; Pu J Gene Ther; 2019 Nov; 27(10-11):495-504. PubMed ID: 32042127 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway. Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA OIP5-AS1 aggravates acute lung injury by promoting inflammation and cell apoptosis via regulating the miR-26a-5p/TLR4 axis. Sun Q; Luo M; Gao Z; Han X; Wu W; Zhao H BMC Pulm Med; 2021 Jul; 21(1):236. PubMed ID: 34261477 [TBL] [Abstract][Full Text] [Related]
7. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies. Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149 [TBL] [Abstract][Full Text] [Related]
8. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis. Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216 [No Abstract] [Full Text] [Related]
9. LncRNA OIP5-AS1 promotes the proliferation and migration of vascular smooth muscle cells via regulating miR-141-3p/HMGB1 pathway. Dong H; Jiang G; Zhang J; Kang Y Am J Med Sci; 2022 Jun; 363(6):538-547. PubMed ID: 35278365 [TBL] [Abstract][Full Text] [Related]
10. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p. Liu Y; Cai X; Cai Y; Chang Y J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of LncRNA OIP5-AS1 Induced by IL-1β Aggravates Osteoarthritis via Regulating miR-29b-3p/PGRN. Zhi L; Zhao J; Zhao H; Qing Z; Liu H; Ma J Cartilage; 2021 Dec; 13(2_suppl):1345S-1355S. PubMed ID: 32037864 [TBL] [Abstract][Full Text] [Related]
12. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis. Zhi XH; Jiang K; Ma YY; Zhou LQ Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Meng X; Ma J; Wang B; Wu X; Liu Z J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer. Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591 [TBL] [Abstract][Full Text] [Related]
15. LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma. Shi C; Yang Q; Pan S; Lin X; Xu G; Luo Y; Zheng B; Xie X; Yu M Cancer Biol Ther; 2020 Jul; 21(7):604-614. PubMed ID: 32329664 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis. Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Wang M; Sun X; Yang Y; Jiao W Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis. Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA OIP5-AS1 regulates smoke-related chronic obstructive pulmonary disease via targeting micro RNA -410-3p/IL-13. Hao W; Lin F; Shi H; Guan Z; Jiang Y Bioengineered; 2021 Dec; 12(2):11664-11676. PubMed ID: 34872453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]